medlinkPeriodontal disease/medlink (PD), a common yet severe gum disease, can be prevented or treated by targeting the medlinkimmune system/medlink.

Discover how targeting the immune system with CCL2 microparticles can prevent and treat periodontal disease, promote bone healing, and reduce...

Maxwell Adeyemi HEMATURIA, otherwise known as blood in urine, can be scary. In many cases the cause is harmless. But blood in urine also can be a...

CELEBRATION, Fla., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare...

LOS ANGELES, Sept. 27 (Xinhua) -- U.S. researchers have identified a gene responsible for some inherited retinal diseases (IRDs), which are a group of...

TUESDAY, Oct. 1, 2024 -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with...

An innovative analysis of shared segments within the genome -; an indication of distant "relatedness" -; has identified undiagnosed cases of Long QT...

The FDA grants orphan drug and rare pediatric disease designations to LBPH's lead pipeline drug for the treatment of Dravet Syndrome.

A new study from the University of Pittsburgh has revealed a promising approach to treating periodontal disease (PD) by targeting the immune system....

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive decline in older adults at...